Cargando…

Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis

Background: Parkinson's disease (PD) and sarcopenia are two common diseases in aging people. To date, the prevalence of sarcopenia in PD patients and the relationship between clinical features and sarcopenia in PD patients are not clear. The aim of the study was to (1) assess the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yingying, Feng, Fei, Wei, Qianqian, Jiang, Zheng, Ou, Ruwei, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973225/
https://www.ncbi.nlm.nih.gov/pubmed/33746871
http://dx.doi.org/10.3389/fneur.2021.598035
_version_ 1783666803874988032
author Cai, Yingying
Feng, Fei
Wei, Qianqian
Jiang, Zheng
Ou, Ruwei
Shang, Huifang
author_facet Cai, Yingying
Feng, Fei
Wei, Qianqian
Jiang, Zheng
Ou, Ruwei
Shang, Huifang
author_sort Cai, Yingying
collection PubMed
description Background: Parkinson's disease (PD) and sarcopenia are two common diseases in aging people. To date, the prevalence of sarcopenia in PD patients and the relationship between clinical features and sarcopenia in PD patients are not clear. The aim of the study was to (1) assess the prevalence of sarcopenia in PD patients and (2) reveal the clinical features between PD patients with and without sarcopenia. Method: A systematic review was carried out through screening PubMed, EMBASE, and Cochrane database in May 2020. All study designs (case–control, cohort, and cross-sectional studies) were eligible for meta-analysis. Data of patients' characteristics, sarcopenia criteria, sarcopenia prevalence, and sarcopenia measures were retrieved. The primary outcome was estimated prevalence of sarcopenia by a pooled prevalence (%) and its 95% confidence interval (CI), using a random-effects model. The secondary outcome was the differences in clinical features between PD patients with and without sarcopenia by meta-analysis. Included articles were assessed for risk of bias. Potential sources of variation were investigated by using subgroup analyses and meta-regression. Result: Ten studies were included in the review. Among them, nine were cross-sectional studies, and one was a prospective cohort study. Age of participants with PD in the studies ranged from 51.1 to 80.7 years. The estimated prevalence of sarcopenia ranged from 6 to 55.5%. The random-effects pooled prevalence was 29% (95% CIs: 0.18–0.40). When only studies at low risk of bias were considered, pooled prevalence decreased to 17% (95% CIs: 0.02–0.33), with still high heterogeneity. The incidence of falls in PD patients with sarcopenia was higher than that in PD patients without sarcopenia. There was no difference in sex ratio between PD patients with and without sarcopenia. Conclusion: Sarcopenia seems to be common in patients with PD. Early assessment of sarcopenia should be implemented in PD to avoid fall and disability.
format Online
Article
Text
id pubmed-7973225
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79732252021-03-20 Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis Cai, Yingying Feng, Fei Wei, Qianqian Jiang, Zheng Ou, Ruwei Shang, Huifang Front Neurol Neurology Background: Parkinson's disease (PD) and sarcopenia are two common diseases in aging people. To date, the prevalence of sarcopenia in PD patients and the relationship between clinical features and sarcopenia in PD patients are not clear. The aim of the study was to (1) assess the prevalence of sarcopenia in PD patients and (2) reveal the clinical features between PD patients with and without sarcopenia. Method: A systematic review was carried out through screening PubMed, EMBASE, and Cochrane database in May 2020. All study designs (case–control, cohort, and cross-sectional studies) were eligible for meta-analysis. Data of patients' characteristics, sarcopenia criteria, sarcopenia prevalence, and sarcopenia measures were retrieved. The primary outcome was estimated prevalence of sarcopenia by a pooled prevalence (%) and its 95% confidence interval (CI), using a random-effects model. The secondary outcome was the differences in clinical features between PD patients with and without sarcopenia by meta-analysis. Included articles were assessed for risk of bias. Potential sources of variation were investigated by using subgroup analyses and meta-regression. Result: Ten studies were included in the review. Among them, nine were cross-sectional studies, and one was a prospective cohort study. Age of participants with PD in the studies ranged from 51.1 to 80.7 years. The estimated prevalence of sarcopenia ranged from 6 to 55.5%. The random-effects pooled prevalence was 29% (95% CIs: 0.18–0.40). When only studies at low risk of bias were considered, pooled prevalence decreased to 17% (95% CIs: 0.02–0.33), with still high heterogeneity. The incidence of falls in PD patients with sarcopenia was higher than that in PD patients without sarcopenia. There was no difference in sex ratio between PD patients with and without sarcopenia. Conclusion: Sarcopenia seems to be common in patients with PD. Early assessment of sarcopenia should be implemented in PD to avoid fall and disability. Frontiers Media S.A. 2021-03-05 /pmc/articles/PMC7973225/ /pubmed/33746871 http://dx.doi.org/10.3389/fneur.2021.598035 Text en Copyright © 2021 Cai, Feng, Wei, Jiang, Ou and Shang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Cai, Yingying
Feng, Fei
Wei, Qianqian
Jiang, Zheng
Ou, Ruwei
Shang, Huifang
Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title_full Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title_fullStr Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title_full_unstemmed Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title_short Sarcopenia in Patients With Parkinson's Disease: A Systematic Review and Meta-Analysis
title_sort sarcopenia in patients with parkinson's disease: a systematic review and meta-analysis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973225/
https://www.ncbi.nlm.nih.gov/pubmed/33746871
http://dx.doi.org/10.3389/fneur.2021.598035
work_keys_str_mv AT caiyingying sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT fengfei sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT weiqianqian sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT jiangzheng sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT ouruwei sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis
AT shanghuifang sarcopeniainpatientswithparkinsonsdiseaseasystematicreviewandmetaanalysis